Historique
Bulletin de Périodique
Drug and Alcohol Dependence , Vol.116, n°1-3 - July 2011
Paru le :
01/07/2011
Année :
2011
Langue(s) :
Anglais
Note de contenu :
CONTENT:
• Conference on abuse liability and appeal of tobacco products: Conclusions and recommendations. Henningfield J.E., Hatsukami D.K., Zeller M., Peters E., p. 1-7.
• Drug use and sport-A commentary on: Injury, pain and prescription opioid use among former National Football League football players by Cottler et al. Strain E.C., p. 8-10.
• Cannabis use and development of externalizing and internalizing behaviour problems in early adolescence: A TRAILS study. Griffith-Lendering M.F., Huijbregts S.C., Mooijaart A., Vollebergh W.A., Swaab H., p. 11-17.
• Striatal hyposensitivity to delayed rewards among cigarette smokers. Luo S., Ainslie G., Giragosian L., Monterosso J.R., p. 18-23.
• Socio-demographic and drug use factors associated with HIV-1 recombinants and dual infections in Northern Thai drug users: Associations of risk with genetic complexity. Kijak G.H., Beyrer C., Tovanabutra S., Sripaipan T., Suriyanon V., Moqueet N., et al., p. 24-30.
• Is there a misplaced focus on AmED? Associations between caffeine mixers and bar patron intoxication. Thombs D., Rossheim M., Barnett T.E., Weiler R.M., Moorhouse M.D., Coleman B.N., p. 31-36.
• Smoking outcome expectancies in young adult female smokers: Individual differences and associations with nicotine dependence in a genetically informative sample. Kristjansson S.D., Pergadia M.L., Agrawal A., Lessov-Schlaggar C.N., McCarthy D.M., Piasecki T.M., et al., p. 37-44.
• The alcohol relapse situation appraisal questionnaire: development and validation. Martin R.A., Mackinnon S.M., Johnson J.E., Myers M.G., Cook T.A., Rohsenow D.J., p. 45-51.
• Factors associated with hepatitis C knowledge among a sample of treatment naive people who inject drugs. Treloar C., Hull P., Bryant J., Hopwood M., Grebely J., Lavis Y., p. 52-56.
• Concordance between self-reports and archival records of physician visits: A case-control study comparing individuals with and without alcohol use disorders in the community. Glass J.E., Bucholz K.K., p. 57-63.
• Correlates of risky injection practices among past-year injection drug users among the US general population. Ropelewski L.R., Mancha B.E., Hulbert A., Rudolph A.E., Martins S.S., p. 64-71.
• Oral administration of levo-tetrahydropalmatine attenuates reinstatement of extinguished cocaine seeking by cocaine, stress or drug-associated cues in rats. Figueroa-Guzman Y., Mueller C., Vranjkovic O., Wisniewski S., Yang Z., Li S.J., et al., p. 72-79.
• Psychoticism and neuroticism predict cocaine dependence and future cocaine use via different mechanisms. Prisciandaro J.J., McRae-Clark A.L., Moran-Santa Maria M.M., Hartwell K.J., Brady K.T., p. 80-85.
• Separate and combined effects of the cannabinoid agonists nabilone and Delta(9)-THC in humans discriminating Delta(9)-THC. Lile J.A., Kelly T.H., Hays L.R., p. 86-92.
• Substance use disorders in Iraq and Afghanistan veterans in VA healthcare, 2001-2010: Implications for screening, diagnosis and treatment. Seal K.H., Cohen G., Waldrop A., Cohen B.E., Maguen S., Ren L., p. 93-101.
• Acute effects of waterpipe tobacco smoking: A double-blind, placebo-control study. Blank M.D., Cobb C.O., Kilgalen B., Austin J., Weaver M.F., Shihadeh A., et al., p. 102-109.
• Failure to sustain prepulse inhibition in adolescent marijuana users. Mathias C.W., Blumenthal T.D., Dawes M.A., Liguori A., Richard D.M., Bray B., et al., p. 110-116.
• Sponsorship and service as mediators of the effects of Making Alcoholics Anonymous Easier (MAAEZ), a 12-step facilitation intervention. Subbaraman M.S., Kaskutas L.A., Zemore S., p. 117-124.
• Conducting a respondent-driven sampling survey with the use of existing resources in Sydney, Australia. Paquette D.M., Bryant J., Crawford S., de Wit J.B., p. 125-131.
• Resisting temptation: Decreasing alcohol-related affect and drinking behavior by training response inhibition. Houben K., Nederkoorn C., Wiers R.W., Jansen A., p. 132-136.
• Standardized measures for substance use stigma. Brown S.A., p. 137-141.
• Dronabinol for the treatment of cannabis dependence: A randomized, double-blind, placebo-controlled trial. Levin F.R., Mariani J.J., Brooks D.J., Pavlicova M., Cheng W., Nunes E.V., p. 142-150.
• Attitudes toward opioid substitution therapy and pre-incarceration HIV transmission behaviors among HIV-infected prisoners in Malaysia: Implications for secondary prevention. Bachireddy C., Bazazi A.R., Kavasery R., Govindasamy S., Kamarulzaman A., Altice F.L., p. 151-157.
• Prescription of analgesics to patients in opioid maintenance therapy: A pharmacoepidemiological study. Fredheim O.M., Borchgrevink P.C., Nordstrand B., Clausen T., Skurtveit S., p. 158-162.
• Agitated depression in substance dependence. Leventhal A.M., Gelernter J., Oslin D., Anton R.F., Farrer L.A., Kranzler H.R., p. 163-169.
• Heavy alcohol use, rather than alcohol dependence, is associated with dysregulation of the hypothalamic-pituitary-adrenal axis and the autonomic nervous system. Boschloo L., Vogelzangs N., Licht C.M., Vreeburg S.A., Smit J.H., van den Brink W., et al., p. 170-176.
• A pilot randomized clinical trial of two medication adherence and drug use interventions for HIV+ crack cocaine users. Ingersoll K.S., Farrell-Carnahan L., Cohen-Filipic J., Heckman C.J., Ceperich S.D., Hettema J., et al., p. 177-187.
• Injury, pain, and prescription opioid use among former National Football League (NFL) players. Cottler L.B., Ben Abdallah A., Cummings S.M., Barr J., Banks R., Forchheimer R., p. 188-194.
• Cost and cost-effectiveness of three strategies for training clinicians in motivational interviewing. Olmstead T., Carroll K.M., Canning-Ball M., Martino S., p. 195-202.
• The sigma receptor agonist SA4503 both attenuates and enhances the effects of methamphetamine. Rodvelt K.R., Oelrichs C.E., Blount L.R., Fan K.H., Lever S.Z., Lever J.R., et al., p. 203-210.
• 3,4-Methylenedioxymethamphetamine (MDMA) alters acute gammaherpesvirus burden and limits interleukin 27 responses in a mouse model of viral infection. Nelson D.A., Singh S.J., Young A.B., Tolbert M.D., Bost K.L., p. 211-221.
• Deconstructing the architecture of alcohol abuse and dependence symptoms in a community sample of late adolescent and emerging adult women: An item response approach. Duncan A.E., Agrawal A., Bucholz K.K., Sartor C.E., Madden P.A., Heath A.C., p. 222-227.
• Determinants of the underreporting of alcohol consumption by HIV/HCV co-infected patients during face-to-face medical interviews: The role of the physician. Roux P., Cohen J., Lascoux-Combe C., Sogni P., Winnock M., Salmon-Ceron D., et al., p. 228-232.
• Treatment for hepatitis C virus genotype 1 infection in HIV-infected individuals on methadone maintenance therapy. Taylor L.E., Bowman S.E., Chapman S., Zaller N., Stein M.D., Cioe P.A., et al., p. 233-237.
• Alexithymia in alcohol dependent patients is partially mediated by alcohol expectancy. Thorberg F.A., Young R.M., Sullivan K.A., Lyvers M., Hurst C.P., Connor J.P., et al., p. 238-241.
• Alcohol consumption associated with collegiate American football pre-game festivities. Merlo L.J., Ahmedani B.K., Barondess D.A., Bohnert K.M., Gold M.S., p. 242-245.
• Multiple substance use among heroin-dependent patients before and during attendance at methadone maintenance treatment program, Yunnan, China. Li L., Sangthong R., Chongsuvivatwong V., McNeil E., Li J., p. 246-249.
• Conference on abuse liability and appeal of tobacco products: Conclusions and recommendations. Henningfield J.E., Hatsukami D.K., Zeller M., Peters E., p. 1-7.
• Drug use and sport-A commentary on: Injury, pain and prescription opioid use among former National Football League football players by Cottler et al. Strain E.C., p. 8-10.
• Cannabis use and development of externalizing and internalizing behaviour problems in early adolescence: A TRAILS study. Griffith-Lendering M.F., Huijbregts S.C., Mooijaart A., Vollebergh W.A., Swaab H., p. 11-17.
• Striatal hyposensitivity to delayed rewards among cigarette smokers. Luo S., Ainslie G., Giragosian L., Monterosso J.R., p. 18-23.
• Socio-demographic and drug use factors associated with HIV-1 recombinants and dual infections in Northern Thai drug users: Associations of risk with genetic complexity. Kijak G.H., Beyrer C., Tovanabutra S., Sripaipan T., Suriyanon V., Moqueet N., et al., p. 24-30.
• Is there a misplaced focus on AmED? Associations between caffeine mixers and bar patron intoxication. Thombs D., Rossheim M., Barnett T.E., Weiler R.M., Moorhouse M.D., Coleman B.N., p. 31-36.
• Smoking outcome expectancies in young adult female smokers: Individual differences and associations with nicotine dependence in a genetically informative sample. Kristjansson S.D., Pergadia M.L., Agrawal A., Lessov-Schlaggar C.N., McCarthy D.M., Piasecki T.M., et al., p. 37-44.
• The alcohol relapse situation appraisal questionnaire: development and validation. Martin R.A., Mackinnon S.M., Johnson J.E., Myers M.G., Cook T.A., Rohsenow D.J., p. 45-51.
• Factors associated with hepatitis C knowledge among a sample of treatment naive people who inject drugs. Treloar C., Hull P., Bryant J., Hopwood M., Grebely J., Lavis Y., p. 52-56.
• Concordance between self-reports and archival records of physician visits: A case-control study comparing individuals with and without alcohol use disorders in the community. Glass J.E., Bucholz K.K., p. 57-63.
• Correlates of risky injection practices among past-year injection drug users among the US general population. Ropelewski L.R., Mancha B.E., Hulbert A., Rudolph A.E., Martins S.S., p. 64-71.
• Oral administration of levo-tetrahydropalmatine attenuates reinstatement of extinguished cocaine seeking by cocaine, stress or drug-associated cues in rats. Figueroa-Guzman Y., Mueller C., Vranjkovic O., Wisniewski S., Yang Z., Li S.J., et al., p. 72-79.
• Psychoticism and neuroticism predict cocaine dependence and future cocaine use via different mechanisms. Prisciandaro J.J., McRae-Clark A.L., Moran-Santa Maria M.M., Hartwell K.J., Brady K.T., p. 80-85.
• Separate and combined effects of the cannabinoid agonists nabilone and Delta(9)-THC in humans discriminating Delta(9)-THC. Lile J.A., Kelly T.H., Hays L.R., p. 86-92.
• Substance use disorders in Iraq and Afghanistan veterans in VA healthcare, 2001-2010: Implications for screening, diagnosis and treatment. Seal K.H., Cohen G., Waldrop A., Cohen B.E., Maguen S., Ren L., p. 93-101.
• Acute effects of waterpipe tobacco smoking: A double-blind, placebo-control study. Blank M.D., Cobb C.O., Kilgalen B., Austin J., Weaver M.F., Shihadeh A., et al., p. 102-109.
• Failure to sustain prepulse inhibition in adolescent marijuana users. Mathias C.W., Blumenthal T.D., Dawes M.A., Liguori A., Richard D.M., Bray B., et al., p. 110-116.
• Sponsorship and service as mediators of the effects of Making Alcoholics Anonymous Easier (MAAEZ), a 12-step facilitation intervention. Subbaraman M.S., Kaskutas L.A., Zemore S., p. 117-124.
• Conducting a respondent-driven sampling survey with the use of existing resources in Sydney, Australia. Paquette D.M., Bryant J., Crawford S., de Wit J.B., p. 125-131.
• Resisting temptation: Decreasing alcohol-related affect and drinking behavior by training response inhibition. Houben K., Nederkoorn C., Wiers R.W., Jansen A., p. 132-136.
• Standardized measures for substance use stigma. Brown S.A., p. 137-141.
• Dronabinol for the treatment of cannabis dependence: A randomized, double-blind, placebo-controlled trial. Levin F.R., Mariani J.J., Brooks D.J., Pavlicova M., Cheng W., Nunes E.V., p. 142-150.
• Attitudes toward opioid substitution therapy and pre-incarceration HIV transmission behaviors among HIV-infected prisoners in Malaysia: Implications for secondary prevention. Bachireddy C., Bazazi A.R., Kavasery R., Govindasamy S., Kamarulzaman A., Altice F.L., p. 151-157.
• Prescription of analgesics to patients in opioid maintenance therapy: A pharmacoepidemiological study. Fredheim O.M., Borchgrevink P.C., Nordstrand B., Clausen T., Skurtveit S., p. 158-162.
• Agitated depression in substance dependence. Leventhal A.M., Gelernter J., Oslin D., Anton R.F., Farrer L.A., Kranzler H.R., p. 163-169.
• Heavy alcohol use, rather than alcohol dependence, is associated with dysregulation of the hypothalamic-pituitary-adrenal axis and the autonomic nervous system. Boschloo L., Vogelzangs N., Licht C.M., Vreeburg S.A., Smit J.H., van den Brink W., et al., p. 170-176.
• A pilot randomized clinical trial of two medication adherence and drug use interventions for HIV+ crack cocaine users. Ingersoll K.S., Farrell-Carnahan L., Cohen-Filipic J., Heckman C.J., Ceperich S.D., Hettema J., et al., p. 177-187.
• Injury, pain, and prescription opioid use among former National Football League (NFL) players. Cottler L.B., Ben Abdallah A., Cummings S.M., Barr J., Banks R., Forchheimer R., p. 188-194.
• Cost and cost-effectiveness of three strategies for training clinicians in motivational interviewing. Olmstead T., Carroll K.M., Canning-Ball M., Martino S., p. 195-202.
• The sigma receptor agonist SA4503 both attenuates and enhances the effects of methamphetamine. Rodvelt K.R., Oelrichs C.E., Blount L.R., Fan K.H., Lever S.Z., Lever J.R., et al., p. 203-210.
• 3,4-Methylenedioxymethamphetamine (MDMA) alters acute gammaherpesvirus burden and limits interleukin 27 responses in a mouse model of viral infection. Nelson D.A., Singh S.J., Young A.B., Tolbert M.D., Bost K.L., p. 211-221.
• Deconstructing the architecture of alcohol abuse and dependence symptoms in a community sample of late adolescent and emerging adult women: An item response approach. Duncan A.E., Agrawal A., Bucholz K.K., Sartor C.E., Madden P.A., Heath A.C., p. 222-227.
• Determinants of the underreporting of alcohol consumption by HIV/HCV co-infected patients during face-to-face medical interviews: The role of the physician. Roux P., Cohen J., Lascoux-Combe C., Sogni P., Winnock M., Salmon-Ceron D., et al., p. 228-232.
• Treatment for hepatitis C virus genotype 1 infection in HIV-infected individuals on methadone maintenance therapy. Taylor L.E., Bowman S.E., Chapman S., Zaller N., Stein M.D., Cioe P.A., et al., p. 233-237.
• Alexithymia in alcohol dependent patients is partially mediated by alcohol expectancy. Thorberg F.A., Young R.M., Sullivan K.A., Lyvers M., Hurst C.P., Connor J.P., et al., p. 238-241.
• Alcohol consumption associated with collegiate American football pre-game festivities. Merlo L.J., Ahmedani B.K., Barondess D.A., Bohnert K.M., Gold M.S., p. 242-245.
• Multiple substance use among heroin-dependent patients before and during attendance at methadone maintenance treatment program, Yunnan, China. Li L., Sangthong R., Chongsuvivatwong V., McNeil E., Li J., p. 246-249.
Dépouillements
Ajouter le résultat à votre sélection
J. E. HENNINGFIELD ;
D. K. HATSUKAMI ;
M. ZELLER ;
E. PETERS
|
2011
Dans Drug and Alcohol Dependence (Vol.116, n°1-3, July 2011) Article : Périodique
Dans Drug and Alcohol Dependence (Vol.116, n°1-3, July 2011) Article : Périodique
The rate of initiation and progression to dependence and premature mortality are higher for tobacco products than for any other dependence producing substance. This is not explained simply by the addictiveness ("abuse liability") or by enticing [...]
Is there a misplaced focus on AmED? Associations between caffeine mixers and bar patron intoxication
D. THOMBS ;
M. ROSSHEIM ;
T. E. BARNETT ;
R. M. WEILER ;
M. D. MOORHOUSE ;
B. N. COLEMAN
|
2011
Dans Drug and Alcohol Dependence (Vol.116, n°1-3, July 2011) Article : Périodique
Dans Drug and Alcohol Dependence (Vol.116, n°1-3, July 2011) Article : Périodique
BACKGROUND: Previous research on alcohol mixed with energy drinks (AmED) suffers from measurement problems. Missing from the research literature are studies that assess caffeine-alcohol co-ingestion in natural drinking environments. METHODS: Thi[...]
J. A. LILE ;
T. H. KELLY ;
L. R. HAYS
|
2011
Dans Drug and Alcohol Dependence (Vol.116, n°1-3, July 2011) Article : Périodique
Dans Drug and Alcohol Dependence (Vol.116, n°1-3, July 2011) Article : Périodique
BACKGROUND: Agonist replacement treatment is a promising strategy to manage cannabis-use disorders. The aim of this study was to assess the combined effects of the synthetic cannabinoid agonist nabilone and Delta(9)-tetrahydrocannabinol (Delta(9[...]
M. D. BLANK ;
C. O. COBB ;
B. KILGALEN ;
J. AUSTIN ;
M. F. WEAVER ;
A. SHIHADEH ;
T. EISSENBERG
|
2011
Dans Drug and Alcohol Dependence (Vol.116, n°1-3, July 2011) Article : Périodique
Dans Drug and Alcohol Dependence (Vol.116, n°1-3, July 2011) Article : Périodique
BACKGROUND: Waterpipe tobacco smoking usually involves heating flavored tobacco with charcoal and inhaling the resulting smoke after it has passed through water. Waterpipe tobacco smoking increases heart rate and produces subjective effects simi[...]
M. S. SUBBARAMAN ;
L. A. KASKUTAS ;
S. ZEMORE
|
2011
Dans Drug and Alcohol Dependence (Vol.116, n°1-3, July 2011) Article : Périodique
Dans Drug and Alcohol Dependence (Vol.116, n°1-3, July 2011) Article : Périodique
A recent trial (n=508) of "Making Alcoholics Anonymous Easier" (MAAEZ), a group-format 12-step facilitation program, showed that MAAEZ participants had increased odds of abstinence (OR=1.58; p=0.063). Effects were especially marked in several su[...]
F. R. LEVIN ;
J. J. MARIANI ;
D. J. BROOKS ;
M. PAVLICOVA ;
W. CHENG ;
E. V. NUNES
|
2011
Dans Drug and Alcohol Dependence (Vol.116, n°1-3, July 2011) Article : Périodique
Dans Drug and Alcohol Dependence (Vol.116, n°1-3, July 2011) Article : Périodique
Cannabis dependence is a substantial public health problem. Behavioral treatments have shown promise, but there are no effective medications for cannabis dependence. The purpose of this study was to evaluate the safety and efficacy of dronabinol[...]